Tenaya Therapeutics (TNYA)
US Market

Tenaya Therapeutics (TNYA) Financial Statements


Tenaya Therapeutics Financial Overview

Tenaya Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.788; its P/E ratio is -0.91; Tenaya Therapeutics is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -34.55M$ -31.30M$ -28.62M$ -31.15M$ -26.16M
EBITDA$ -32.43M$ -29.21M$ -27.32M$ -30.19M$ -25.37M
Net Income Common Stockholders$ -33.52M$ -30.70M$ -28.40M$ -31.06M$ -26.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 186.53M$ 149.45M$ 180.92M$ 210.45M$ 251.30M
Total Assets$ 278.94M$ 226.31M$ 255.93M$ 281.50M$ 314.19M
Total Debt$ 15.10M$ 16.06M$ 17.00M$ 15.17M$ 15.70M
Net Debt$ -171.43M$ -133.39M$ -163.92M$ -195.29M$ -235.60M
Total Liabilities$ 35.57M$ 29.98M$ 32.06M$ 32.40M$ 35.66M
Stockholders Equity$ 243.38M$ 196.33M$ 223.87M$ 249.10M$ 278.53M
Cash Flow-
Free Cash Flow$ -23.48M$ -31.62M$ -32.61M$ -37.35M$ -28.90M
Operating Cash Flow$ -22.68M$ -27.56M$ -25.43M$ -28.76M$ -16.35M
Investing Cash Flow$ 5.97M$ 31.03M$ 30.21M$ 16.43M$ -62.58M
Financing Cash Flow$ 77.49M$ 6.00K$ 260.00K$ 15.00K$ -21.00K
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Tenaya Therapeutics Debt to Assets

Tenaya Therapeutics Cash Flow

Tenaya Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis